On October 7, 2025, PAVmed Inc. and its majority‑owned subsidiary Veris Health announced that Veris and the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have launched the commercial phase of their long‑term strategic partnership agreement. The announcement, published by PRNewswire on October 8, 2025, marks the transition from a pilot program to full commercial engagement between the parties.
The Veris Cancer Care Platform is a comprehensive digital health solution that collects remote physiological data, enables symptom reporting, offers telehealth capabilities, and integrates with electronic health records. Patients enrolled on the platform receive a VerisBox of connected health devices that transmit data to a cloud‑based clinician portal via embedded cellular connections, while a complementary patient portal allows symptom and quality‑of‑life reporting through a smartphone app.
By launching the commercial phase, Veris and OSUCCC – James are expanding the platform’s deployment across the cancer center’s ambulatory clinics and hospital settings, and they have initiated a clinical registry for patients enrolled on the platform. This milestone is expected to accelerate revenue generation for PAVmed by broadening market penetration and establishing a scalable, data‑driven oncology care model.
The partnership also highlights Veris’s ongoing development of an implantable physiological monitor designed to be implanted alongside a chemotherapy port. While the monitor is still in development, its integration with the platform could further enhance the commercial value of the partnership by providing continuous, device‑independent physiological data for cancer patients.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.